Ren Hezhen, Pors Jennifer, Chow Christine, Ta Monica, Stolnicu Simona, Soslow Robert, Huntsman David, Hoang Lynn
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Genetic Pathology Evaluation Center (GPEC), Vancouver, BC, Canada.
J Pathol Transl Med. 2020 Nov;54(6):480-488. doi: 10.4132/jptm.2020.07.18. Epub 2020 Aug 31.
The International Endocervical Adenocarcinoma Criteria and Classification (IECC) separated endocervical adenocarcinomas into human papillomavirus (HPV) associated (HPVA) and non-HPV-associated (NHPVA) categories by morphology alone. Our primary objective was to assess the accuracy of HPV prediction by the IECC system compared to p16 immunohistochemistry and HPV RNA in-situ hybridization (RISH). Our secondary goal was to directly compare p16 and HPV RISH concordance.
Cases were classified by IECC and stained for p16 and HPV RISH on tissue microarray, with discordant p16/HPV RISH cases re-stained on whole tissue sections. Remaining discordant cases (p16/HPV, IECC/p16, IECC/HPV discordances) were re-reviewed by the original pathologists (n = 3) and external expert pathologists (n = 2) blinded to the p16 and HPV RISH results. Final IECC diagnosis was assigned upon independent agreement between all reviewers.
One hundred and eleven endocervical adenocarcinomas were classified originally into 94 HPVA and 17 NHPVA cases. p16 and HPV RISH was concordant in 108/111 cases (97%) independent of the IECC. HPV RISH and p16 was concordant with IECC in 103/111 (93%) and 106/111 (95%), respectively. After expert review, concordance improved to 107/111 (96%) for HPV RISH. After review of the eight discordant cases, one remained as HPVA, four were reclassified to NHPVA from HPVA, two were unclassifiable, and one possibly represented a mixed usual and gastric-type adenocarcinoma.
p16 and HPV RISH have excellent concordance in endocervical adenocarcinomas, and IECC can predict HPV status in most cases. Focal apical mitoses and apoptotic debris on original review led to the misclassification of several NHPVA as HPVA.
国际宫颈管腺癌标准与分类(IECC)仅依据形态学将宫颈管腺癌分为人乳头瘤病毒(HPV)相关型(HPVA)和非HPV相关型(NHPVA)。我们的主要目的是评估与p16免疫组化及HPV RNA原位杂交(RISH)相比,IECC系统预测HPV的准确性。我们的次要目标是直接比较p16与HPV RISH的一致性。
根据IECC对病例进行分类,并在组织芯片上进行p16和HPV RISH染色,p16/HPV RISH结果不一致的病例在全组织切片上重新染色。其余不一致的病例(p16/HPV、IECC/p16、IECC/HPV不一致)由最初的病理学家(n = 3)和对p16和HPV RISH结果不知情的外部专家病理学家(n = 2)重新审查。所有审阅者达成独立一致意见后确定最终的IECC诊断。
111例宫颈管腺癌最初被分为94例HPVA和17例NHPVA。独立于IECC,p16和HPV RISH在108/111例(97%)中结果一致。HPV RISH和p16分别与IECC在103/111(93%)和 &